play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
volume_up
chevron_left

Fresh Podcasting Experience

Subscribe

Background

Latest Podcast

Medspresso Podcast
play_arrow
share playlist_add
close

Featured

Empiric Antimicrobials used in Hospital

Dr Swapnil Pawar September 13, 2024

Emiric Antimicrobials in Hospital Written by – Dr Andrew Lam Penicillins MoA: Beta lactam ring binds to Penicillin Binding Protein (PBP) on cell walls. As a result, they prevent cross-linking and cell wall synthesis leading to cell death Benzylpenicillin – Narrow Spectrum: Streptococcus, Listeria, Syphilis Flucloxacillin – MSSA Addition of further beta lactam inhibitors helps to broaden spectrum of activity: Amoxicillin + Clavulanate (Augmentin)  Piperacillin + Tazobactam (Tazocin)  Cephalosporins MoA: As per penicillins, but altered beta lactam ring confers resistance to some beta lactamases Cefazolin – Mostly gram positive cover, some gram negative cover -> used for skin infections and […]

Read more trending_flat

Medspresso Podcast
play_arrow
share playlist_add
close

Opioids

Analgesics

Dr Swapnil Pawar August 1, 2024

Analgesics Written by Dr Andrew Lam ParacetamolMoA: COX inhibition preventing prostaglandin synthesis Prevention of re-uptake of endocannabinoids Enhancement of inhibitory serotonergic pathways Side Effects: Generally well tolerated. Hepatotoxicity in overdose, hypotension with IV administration NSAID’s Non-Selective (i.e. Ibuprofen) MoA: Inhibition of COX 2 +/- COX 1 to decrease prostaglandin synthesis and hence, pain transmission Side Effects: Renal dysfunction, GI ulceration/bleeding, and platelet dysfunction COX-2 Selective (i.e. Celecoxib) MoA: Selective inhibition of COX 2 to decrease prostaglandin synthesis and hence, pain transmission Side Effects: Myocardial infarction, stroke, renal dysfunction Opioids MoA: Primarily μ GPCR agonistic activity but also has some weak […]

Read more trending_flat

ICU Fellowship PrepCast
insert_link share playlist_add
close

Podcasting

ICU Fellowship Snippet – Type 1 Respiratory failure in immunocompramised patient

Dr Swapnil Pawar July 5, 2024

Written by Dr Madhuri Anupindi 42M admitted to ICU day 4 post induction chemotherapy for APML. The patient was initially treated with idarubicin and all-trans retinoic acid (ATRA). He has become progressively more dyspnoeac in the ward. CXR demonstrates a bilateral, diffuse pulmonary infiltrate. Initial exam reveals RR 40, sats 88% on 10L via face mask, GCS 14 (E4V4M6), temp 38.9, Hr 144, BP 95/50. Full blood count on admission shows Hb 88 WCC 26 and platelets 22 with blasts visible. INR 3.2. Suggest a differential diagnosis. There are multiple potential causes for this gentleman’s respiratory failure, both infective (of […]

Read more trending_flat

Browse By Topic